Oncolytics Biotech Inc T.ONC

BC competition

[m00nsh0ts]

https://endpts.com/gileads-trodelvy-scores-surprise-os-win-in-metastatic-breast-cancer-but-data-will-wait-for-an-upcoming-conference/

[Noteable]

Trodelvy is a chemotherapy- ADC  acquired through Gilead's acquisition of Immunomedics for USD$21 Billion, and whose competition is AstraZeneca / Daiichi's Enhertu. They work by delivering chemotherapy directly to the cancer cell. - far different from ONCY's pelareorep in combination with immune checkpoint hinibitors.

[m00nsh0ts]

Thanks for the explanation

[fox7mf]

In any event, Oncy needs to negotiate a buyout as competition will continue to proliferate.